...
首页> 外文期刊>The Biochemical Journal >Endoplasmic reticulum chaperones inhibit the production of amyloid-beta peptides.
【24h】

Endoplasmic reticulum chaperones inhibit the production of amyloid-beta peptides.

机译:内质网伴侣分子抑制淀粉样β肽的产生。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abeta (amyloid-beta peptides) generated by proteolysis of APP (beta-amyloid precursor protein), play an important role in the pathogenesis of AD (Alzheimer's disease). ER (endoplasmic reticulum) chaperones, such as GRP78 (glucose-regulated protein 78), make a major contribution to protein quality control in the ER. In the present study, we examined the effect of overexpression of various ER chaperones on the production of Abeta in cultured cells, which produce a mutant type of APP (APPsw). Overexpression of GRP78 or inhibition of its basal expression, decreased and increased respectively the level of Abeta40 and Abeta42 in conditioned medium. Co-expression of GRP78's co-chaperones ERdj3 or ERdj4 stimulated this inhibitory effect of GRP78. In the case of the other ER chaperones, overexpression of some (150 kDa oxygen-regulated protein and calnexin) but not others (GRP94 and calreticulin) suppressed the production of Abeta. These results indicate that certain ER chaperones are effective suppressors of Abeta production and that non-toxic inducers of ER chaperones may be therapeutically beneficial for AD treatment. GRP78 was co-immunoprecipitated with APP and overexpression of GRP78 inhibited the maturation of APP, suggesting that GRP78 binds directly to APP and inhibits its maturation, resulting in suppression of the proteolysis of APP. On the other hand, overproduction of APPsw or addition of synthetic Abeta42 caused up-regulation of the mRNA of various ER chaperones in cells. Furthermore, in the cortex and hippocampus of transgenic mice expressing APPsw, the mRNA of some ER chaperones was up-regulated in comparison with wild-type mice. We consider that this up-regulation is a cellular protective response against Abeta.
机译:通过APP(β-淀粉样蛋白前体蛋白)的蛋白水解产生的Abeta(淀粉样蛋白-β肽)在AD(阿尔茨海默氏病)的发病机理中起着重要作用。 ER(内质网)分子伴侣,例如GRP78(葡萄糖调节蛋白78),对ER中的蛋白质质量控​​制做出了重要贡献。在本研究中,我们检查了各种ER伴侣蛋白过表达对培养细胞中Abeta产生的影响,该细胞产生APP(APPsw)突变型。在条件培养基中,GRP78的过表达或对其基础表达的抑制分别降低和增加了Abeta40和Abeta42的水平。 GRP78的伴侣伴侣ERdj3或ERdj4的共表达刺激了GRP78的这种抑制作用。在其他ER伴侣的情况下,某些(150 kDa的氧气调节蛋白和钙联接蛋白)的过表达抑制了其他(GRP94和钙网蛋白)的表达抑制了Abeta的产生。这些结果表明,某些ER分子伴侣是Abeta产生的有效抑制剂,而ER分子伴侣的无毒诱导剂可能对AD治疗有益。 GRP78与APP共免疫沉淀,GRP78的过表达抑制APP的成熟,表明GRP78直接与APP结合并抑制其成熟,从而导致APP的蛋白水解受到抑制。另一方面,APPsw的过量生产或合成Abeta42的添加导致细胞中各种ER伴侣的mRNA上调。此外,在表达APPsw的转基因小鼠的皮质和海马中,与野生型小鼠相比,一些ER伴侣的mRNA被上调。我们认为这种上调是针对Abeta的细胞保护反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号